EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Production of human cathepsins using Expi293™ mammalian cell expression system for off‐target activity of cysteine protease inhibitor screening

Zoe Turner, Elena Arutyunova iD, Duong T Bui iD, Ling Han iD, Appan Srinivas Kandadai, Bing Bai, Howard S Young, Lara K Mahal iD, John S Klassen iD, M Joanne Lemieux

Protein Science · 2025

DOI: 10.1002/pro.70361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, 2025. Verfasst von Zoe Turner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Cysteine Proteinase Inhibitors, Cathepsins, Antiviral Agents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Alberta Innovation and Advanced Education Research Capacity Program, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research Rapid Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following the SARS‐CoV‐2 pandemic, many direct‐acting antivirals targeting viral cysteine protease were developed. SARS‐CoV‐2, as well as other viruses, rely on cysteine proteases for their replication, suggesting future generations of antivirals targeting cysteine proteases will emerge. A major concern for these first‐generation drugs is the off‐target effects on host cysteine proteases. Therefore, screening for inhibitor specificity is a crucial step in antiviral drug development. Cathepsins are one of the most abundant human proteases, which have roles in maintaining cell health and are key to many physiological processes. Here we describe a general expression and purification protocol for cathepsins B, S, and L using the Expi293™ mammalian expression system. We characterized the glycosylation pattern and kinetic parameters of purified enzymes with commercially available cathepsin‐specific fluorogenic substrates and also established cathepsin inhibition screen assays. We tested specificity indices of peptidic inhibitors of SARS‐CoV‐2 M pro synthesized by our team and nirmatrelvir as a benchmark for all three cathepsins. Establishing a reliable cathepsin inhibition assay would assist with screening of newly developed cysteine protease inhibitors for off‐target activity within the scope of pandemic preparedness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cysteine Proteinase InhibitorsCathepsinsAntiviral AgentsHumansSARS-CoV-2Cathepsin LHEK293 CellsRecombinant ProteinsCathepsin B

Stichwörter der Autor:innen

SARS‐CoV‐2 inhibitorsantiviralscathepsinscysteine proteaseoff‐target activity

Substanzen

Cysteine Proteinase InhibitorsCathepsinsCTSL protein, humanCathepsin Lcathepsin SCTSB protein, humanAntiviral AgentsRecombinant ProteinsCathepsin B

Autor:innen und Institutionen

  • Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
  • Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Chemistry, University of Alberta, Alberta, Canada.
  • Li Ka Shing Applied Virology Institute, University of Alberta, Edmonton, Alberta, Canada.

ORCID-Profile: Elena Arutyunova, Duong T Bui, Ling Han, Lara K Mahal, John S Klassen

Förderung

  • Alberta Innovation and Advanced Education Research Capacity Program
  • Natural Sciences and Engineering Research Council of Canada
  • Canadian Institutes of Health Research Rapid Research
  • Canada Excellence Research Chairs, Government of Canada
  • Canada Foundation for Innovation

Zitieren

APA

Turner, Z., Arutyunova, E., Bui, D. T., Han, L., Kandadai, A. S., Bai, B., Young, H. S., Mahal, L. K., Klassen, J. S., & Lemieux, M. J. (2025). Production of human cathepsins using Expi293™ mammalian cell expression system for off‐target activity of cysteine protease inhibitor screening. Protein Science. https://doi.org/10.1002/pro.70361

Vancouver

Turner Z, Arutyunova E, Bui DT, Han L, Kandadai AS, Bai B, et al. Production of human cathepsins using Expi293™ mammalian cell expression system for off‐target activity of cysteine protease inhibitor screening. Protein Science. 2025. doi:10.1002/pro.70361

BibTeX
@article{Turner2025,
  author = {Turner, Zoe and Arutyunova, Elena and Bui, Duong T and Han, Ling and Kandadai, Appan Srinivas and Bai, Bing and Young, Howard S and Mahal, Lara K and Klassen, John S and Lemieux, M Joanne},
  title = {Production of human cathepsins using Expi293™ mammalian cell expression system for off‐target activity of cysteine protease inhibitor screening},
  journal = {Protein Science},
  year = {2025},
  doi = {10.1002/pro.70361}
}
Kostenlos starten →